Vigabatrin



Indications and Reactions:

Role Indications Reactions
Primary
Infantile Spasms 66.7%
Complex Partial Seizures 11.1%
Lennox-gastaut Syndrome 11.1%
Quadriparesis 11.1%
Convulsion 20.0%
Dystonia 20.0%
Movement Disorder 20.0%
Opisthotonus 20.0%
Thrombocytopenia 20.0%
Secondary
Epilepsy 35.2%
Convulsion 12.6%
Product Used For Unknown Indication 8.2%
Status Epilepticus 7.3%
Partial Seizures 6.4%
Foetal Exposure During Pregnancy 3.9%
Grand Mal Convulsion 3.4%
Lennox-gastaut Syndrome 3.4%
Drug Use For Unknown Indication 3.0%
Infantile Spasms 3.0%
Drug Exposure During Pregnancy 2.1%
Asthenia 1.6%
Dyspnoea 1.6%
Pyrexia 1.6%
Tuberous Sclerosis 1.6%
Breast Cancer Metastatic 1.4%
Diabetes Mellitus 1.4%
Complex Partial Seizures 0.9%
Petit Mal Epilepsy 0.9%
Porphyria Acute 0.7%
Status Epilepticus 15.0%
Drug Exposure During Pregnancy 8.3%
Hydronephrosis 6.7%
Neonatal Behavioural Syndrome 6.7%
Sudden Unexplained Death In Epilepsy 6.7%
Drug Ineffective 5.0%
Osteoporosis 5.0%
Partial Seizures 5.0%
Suicide Attempt 5.0%
Vomiting 5.0%
Inappropriate Antidiuretic Hormone Secretion 3.3%
Maternal Exposure During Pregnancy 3.3%
Normal Newborn 3.3%
Nuclear Magnetic Resonance Imaging Brain Abnormal 3.3%
Penis Disorder 3.3%
Petit Mal Epilepsy 3.3%
Pneumonia 3.3%
Swelling Face 3.3%
Vesicoureteric Reflux 3.3%
Complex Partial Seizures 1.7%
Concomitant
Epilepsy 58.5%
Drug Use For Unknown Indication 7.4%
Infantile Spasms 6.8%
Convulsion 5.9%
Product Used For Unknown Indication 3.8%
Gastrooesophageal Reflux Disease 2.7%
Lennox-gastaut Syndrome 1.9%
Grand Mal Convulsion 1.6%
Partial Seizures 1.6%
Tuberous Sclerosis 1.4%
Myoclonic Epilepsy 1.3%
Prophylaxis 1.1%
Asthma 0.9%
Blood Pressure 0.9%
Insomnia 0.9%
Pneumonia 0.9%
Early Infantile Epileptic Encephalopathy With Burst-suppression 0.8%
Astrocytoma, Low Grade 0.5%
Breast Cancer Metastatic 0.5%
Bronchopulmonary Dysplasia 0.5%
Vomiting 15.1%
Tracheo-oesophageal Fistula 12.3%
Vesicoureteric Reflux 9.4%
Convulsion 6.6%
Thrombocytopenia 6.6%
Epilepsy 5.7%
Pallor 5.7%
Somnolence 5.7%
Pyrexia 4.7%
Drug Interaction 3.8%
Status Epilepticus 3.8%
Cough 2.8%
Drug Ineffective 2.8%
Hypoglycaemia 2.8%
Hypotonia 2.8%
Death 1.9%
Hydronephrosis 1.9%
Pulmonary Hypertension 1.9%
Renal Failure 1.9%
Respiratory Distress 1.9%
Interacting
Partial Seizures 100.0%
Drug Interaction 50.0%
Urinary Incontinence 50.0%